| Phase 4 |
| NCT05518383 |
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 |
Non-hodgkin Lymphoma,B Cell |
Recruiting |
| Phase 3 |
| NCT05549167 |
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal… |
Juvenile Nasopharyngeal Angiofibroma |
Recruiting |
| NCT06071897 |
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma |
Neuroblastoma |
Recruiting |
| NCT05029531 |
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia… |
Acute Lymphoblastic Leukemia, Pediatric |
Recruiting |
| NCT07232134 |
The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in… |
AML (Acute Myelogenous Leukemia) |
Recruiting |
| NCT07375563 |
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With… |
Neuroblastoma (NB) |
Recruiting |
| NCT05515029 |
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| Phase 2/3 |
| NCT06756152 |
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… |
Biphenotypic Acute Leukemia |
Recruiting |
| NCT07366801 |
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell… |
Acute Myeloid Leukemia, Relapsed |
Recruiting |
| NCT06475820 |
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| Phase 2 |
| NCT06198842 |
Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage… |
Nijmegen Breakage Syndrome |
Recruiting |
| NCT06199427 |
PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in… |
Inborn Errors of Immunity |
Recruiting |
| NCT07256210 |
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse… |
Acute Myeloid Leukemia |
Recruiting |
| NCT07316595 |
Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome |
HSCT |
Not Yet Recruiting |
| Phase 1/2 |
| NCT04499573 |
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL |
B-ALL |
Active, Not Recruiting |
| Not specified |
| NCT06296732 |
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification |
Neuroblastoma |
Recruiting |
| NCT06587191 |
Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis |
Primary Hemophagocytic Lymphohistiocytosis |
Active, Not Recruiting |